104 related articles for article (PubMed ID: 34107580)
1. [Effect of miR-23b on the malignant phenotype and the sensitivity of lenvatinib in human hepatocellular carcinoma cells].
Yan WN; Li SB; Ma HJ; Chen DD; Wang J; Le T; Zhang GQ
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):433-438. PubMed ID: 34107580
[No Abstract] [Full Text] [Related]
2. [Over-expression of Hsa-miR-23b-3p suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of human cervical cancer CasKi cells].
Hu J; Sun Z; Hu K; Tang M; Sun S; Fang Y; Yu H; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):983-989. PubMed ID: 33210592
[TBL] [Abstract][Full Text] [Related]
3. miR-23b-3p Plays an Oncogenic Role in Hepatocellular Carcinoma.
Hayashi M; Yamada S; Kurimoto K; Tanabe H; Hirabayashi S; Sonohara F; Inokawa Y; Takami H; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Ann Surg Oncol; 2021 Jun; 28(6):3416-3426. PubMed ID: 33140250
[TBL] [Abstract][Full Text] [Related]
4. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
Xu Q; Cai W; Zhang M; Liu Q; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
[TBL] [Abstract][Full Text] [Related]
5. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.
Najafi Z; Sharifi M; Javadi G
J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
Grossi I; Arici B; Portolani N; De Petro G; Salvi A
Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
9. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
10. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment.
Cao X; Xu L; Liu Q; Yang L; Li N; Li X
Oncol Res; 2019 Feb; 27(3):301-309. PubMed ID: 29562958
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral-mediated microRNA-26b up-regulation inhibits proliferation and migration of hepatocellular carcinoma cells.
Lin CZ; Ou RW; Hu YH
Kaohsiung J Med Sci; 2018 Oct; 34(10):547-555. PubMed ID: 30309482
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells.
Ao J; Chiba T; Shibata S; Kurosugi A; Qiang N; Ma Y; Kan M; Iwanaga T; Sakuma T; Kanzaki H; Kanayama K; Kojima R; Kusakabe Y; Nakamura M; Saito T; Nakagawa R; Kondo T; Ogasawara S; Suzuki E; Muroyama R; Kato J; Mimura N; Kanda T; Maruyama H; Kato N
Biochem Biophys Res Commun; 2021 Apr; 549():171-178. PubMed ID: 33676186
[TBL] [Abstract][Full Text] [Related]
13. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families.
He XX; Shi LL; Qiu MJ; Li QT; Wang MM; Xiong ZF; Yang SL
Biochem Biophys Res Commun; 2018 Oct; 504(4):878-884. PubMed ID: 30219235
[TBL] [Abstract][Full Text] [Related]
14. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
15. miR-449a regulates biological functions of hepatocellular carcinoma cells by targeting SATB1.
Li J; Zheng Z; Zhang J; Tang Y; Wan X
J BUON; 2020; 25(3):1375-1382. PubMed ID: 32862579
[TBL] [Abstract][Full Text] [Related]
16. MiR-224 Executes a Tumor Accelerative Role during Hepatocellular Carcinoma Malignancy by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 3.
Miao K; Liu SD; Huang WX; Dong H
Pharmacology; 2020; 105(7-8):477-487. PubMed ID: 32454494
[TBL] [Abstract][Full Text] [Related]
17. [Expression of miR-495 and its effect on MHCC-97H hepatocellular carcinoma cells].
Wang YY; Zhang ZR; Li J; Ren HL
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):571-574. PubMed ID: 34225433
[No Abstract] [Full Text] [Related]
18. Evaluation of the diagnostic and therapeutic roles of non-coding RNA and cell proliferation related gene association in hepatocellular carcinoma.
Ahmed MY; Salah MM; Kassim SK; Abdelaal A; Elayat WM; Mohamed DA; Fouly AE; Abu-Zahra FAE
Gene; 2019 Jul; 706():97-105. PubMed ID: 31034943
[TBL] [Abstract][Full Text] [Related]
19. [Study on the expression of non-coding microRNA-376b-3p in serum exosomes of patients with malignant glioma and the mechanism of anti-angiogenesis].
Jiang J; Wang S; Meng QH; Yu R; Wei SC; Wang J; Qu CC; Wang CW
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1634-1639. PubMed ID: 32486598
[No Abstract] [Full Text] [Related]
20. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
